Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

Author:

Deodhar Atul1,Poddubnyy Denis2ORCID,Pacheco‐Tena Cesar3,Salvarani Carlo4,Lespessailles Eric5,Rahman Proton6,Järvinen Pentti7,Sanchez‐Burson Juan8,Gaffney Karl9,Lee Eun Bong10,Krishnan Eswar11,Santisteban Silvia11,Li Xiaoqi11,Zhao Fangyi11,Carlier Hilde11,Reveille John D.12,Antolini Christopher,Azevedo Valderilio,Barkham Magnus,Rodriguez Aaron Alejandro Barrera,Berman Alberto,Blicharski Tomasz,Brzezicki Jan,Burmester Gerd,Carrio Judith,Collantes Eduardo,Combe Bernard,Cons‐Molina Fidencio,Cortes‐Maisonet Gregorio,Dudek Anna,Barragan Sergio Duran,Elkayam Ori,Flint Kathleen,Galeazzi Mauro,Gaylis Norman,Goddard David,Fernandez Carlos Gonzalez,Goupille Philippe,Masmitja Jordi Gratacos,Greenwald Maria,Gremese Elisa,Hong Seung Jae,Howell Mary,Hrycaj Pawel,Ince Akgun,Ju Ji Hyeon,Kaine Jeffrey,Kang Seong Wook,Keiserman Mauro,Kim Tae‐Hwan,Kivitz Alan,Klein Steven,Kremer Joel,Lee Sang Heon,Lee Chang Keun,Lee Sang‐Hoon,Lidman Roger,Loveless James,Lucero Eleonora,Cocco Jose Maldonado,Marcolino Flora,Mariette Xavier,Mehta Daksha,Morin Frederic,Moscovici Yolanda,Mueller Eric,Mysler Eduardo,Blasco Francisco Navarro,Nguyen Minh,Pantojas Carlos,Park Min‐Chan,Jesus Amarilis Perez‐De,Peters Eric,Plebanski Rafal,Querubin Roel,Remus Cesar Ramos,Reitblat Tatiana,Rivera Tania,Rodriguez Juan Cruz Rizo,Sayers Michael,Scotton Antonio,Scoville Craig,Shaw David,Shin Kichul,Singhal Atul,Skinner Cassandra,Soto‐Raices Oscar,Soubrier Martin,Szymanska Malgorzata,Thai Christine,Sande Marleen,Wells Alvin,Wojciechowski Rafal,Xavier Ricardo,Ximenes Antonio,Zisman Devy,

Affiliation:

1. Oregon Health & Science University Portland

2. Universitätsmedizin Berlin and German Rheumatism Research Centre Berlin Germany

3. Universidad Autónoma de Chihuahua Chihuahua Deodhar Mexico

4. Azienda USL‐IRCCS di Reggio Emilia and Universita’ di Modena e Reggio Emilia Reggio Emilia Italy

5. University of Orléans Orléans France

6. Memorial University St. John’s Newfoundland Canada

7. Kiljava Medical Research Hyvinkää Finland

8. Hospital Infanta Luisa Seville Spain

9. Norfolk and Norwich Hospital NHS Foundation Trust and University of East Anglia Norwich UK

10. Seoul National University College of Medicine Seoul Republic of Korea

11. Eli Lilly and Company Indianapolis Indiana

12. University of Texas‐McGovern Medical School Houston

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3